RDC-0313

· Alkermes, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RDC-0313, covering 2011-08-22 to 2017-01-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults [Phase 1]

See pricing